Halozyme Therapeutics Inc (HALO)

[maumar]

I don't know how bright they are but if you have not seen MLV's "probability-adjusted sum-of-the-parts analysis" with a $20 price target, here is a link:

http://www.smarteranalyst.com/2015/03/03/mlv-maintains-buy-rating-halozyme-therapeutics-following-line-4q-results/

I think it's pretty conservative and we'll go much higher eventually.